Glaukos (GKOS)
(Delayed Data from NYSE)
$82.10 USD
-0.25 (-0.30%)
Updated Sep 17, 2025 04:00 PM ET
Pre-Market: $83.08 +0.98 (1.19%) 8:01 AM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Glaukos Corporation has a market cap of $4.72B, which represents its share price of $82.35 multiplied by its outstanding shares number of 57.35M. As a mid-cap company, GKOS's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GKOS 82.10 -0.25(-0.30%)
Will GKOS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GKOS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GKOS
Glaukos Builds Dual Growth Engines Amid Market Headwinds
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
GKOS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks
What Makes Glaukos (GKOS) a New Buy Stock
Other News for GKOS
Needham medtech & diagnostics analysts hold analyst/industry conference call
Is GKOS ready to move higher? Stochastic Buy Signal shows up after gaining 2.12%
Needham medtech & diagnostics analysts hold analyst/industry conference call
Glaukos (GKOS) Gains Positive Attention from Stifel Analyst
Stifel sees opportunity in Glaukos selloff, adds to Select List